Global Venous Thromboembolism Therapeutics Market Insights and Forecast to 2028

Global Venous Thromboembolism Therapeutics Market Insights and Forecast to 2028

Table of Contents
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Venous Thromboembolism Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Factor Xa Inhibitors
1.2.3 Direct Thrombin Inhibitors
1.2.4 Heparin
1.2.5 Vitamin K Antagonists
1.2.6 Other
1.3 Market by Application
1.3.1 Global Venous Thromboembolism Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Venous Thromboembolism Therapeutics Market Perspective (2017-2028)
2.2 Venous Thromboembolism Therapeutics Growth Trends by Region
2.2.1 Venous Thromboembolism Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Venous Thromboembolism Therapeutics Historic Market Size by Region (2017-2022)
2.2.3 Venous Thromboembolism Therapeutics Forecasted Market Size by Region (2023-2028)
2.3 Venous Thromboembolism Therapeutics Market Dynamics
2.3.1 Venous Thromboembolism Therapeutics Industry Trends
2.3.2 Venous Thromboembolism Therapeutics Market Drivers
2.3.3 Venous Thromboembolism Therapeutics Market Challenges
2.3.4 Venous Thromboembolism Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Venous Thromboembolism Therapeutics Players by Revenue
3.1.1 Global Top Venous Thromboembolism Therapeutics Players by Revenue (2017-2022)
3.1.2 Global Venous Thromboembolism Therapeutics Revenue Market Share by Players (2017-2022)
3.2 Global Venous Thromboembolism Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Venous Thromboembolism Therapeutics Revenue
3.4 Global Venous Thromboembolism Therapeutics Market Concentration Ratio
3.4.1 Global Venous Thromboembolism Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Venous Thromboembolism Therapeutics Revenue in 2021
3.5 Venous Thromboembolism Therapeutics Key Players Head office and Area Served
3.6 Key Players Venous Thromboembolism Therapeutics Product Solution and Service
3.7 Date of Enter into Venous Thromboembolism Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Venous Thromboembolism Therapeutics Breakdown Data by Type
4.1 Global Venous Thromboembolism Therapeutics Historic Market Size by Type (2017-2022)
4.2 Global Venous Thromboembolism Therapeutics Forecasted Market Size by Type (2023-2028)
5 Venous Thromboembolism Therapeutics Breakdown Data by Application
5.1 Global Venous Thromboembolism Therapeutics Historic Market Size by Application (2017-2022)
5.2 Global Venous Thromboembolism Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Venous Thromboembolism Therapeutics Market Size (2017-2028)
6.2 North America Venous Thromboembolism Therapeutics Market Size by Type
6.2.1 North America Venous Thromboembolism Therapeutics Market Size by Type (2017-2022)
6.2.2 North America Venous Thromboembolism Therapeutics Market Size by Type (2023-2028)
6.2.3 North America Venous Thromboembolism Therapeutics Market Share by Type (2017-2028)
6.3 North America Venous Thromboembolism Therapeutics Market Size by Application
6.3.1 North America Venous Thromboembolism Therapeutics Market Size by Application (2017-2022)
6.3.2 North America Venous Thromboembolism Therapeutics Market Size by Application (2023-2028)
6.3.3 North America Venous Thromboembolism Therapeutics Market Share by Application (2017-2028)
6.4 North America Venous Thromboembolism Therapeutics Market Size by Country
6.4.1 North America Venous Thromboembolism Therapeutics Market Size by Country (2017-2022)
6.4.2 North America Venous Thromboembolism Therapeutics Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Venous Thromboembolism Therapeutics Market Size (2017-2028)
7.2 Europe Venous Thromboembolism Therapeutics Market Size by Type
7.2.1 Europe Venous Thromboembolism Therapeutics Market Size by Type (2017-2022)
7.2.2 Europe Venous Thromboembolism Therapeutics Market Size by Type (2023-2028)
7.2.3 Europe Venous Thromboembolism Therapeutics Market Share by Type (2017-2028)
7.3 Europe Venous Thromboembolism Therapeutics Market Size by Application
7.3.1 Europe Venous Thromboembolism Therapeutics Market Size by Application (2017-2022)
7.3.2 Europe Venous Thromboembolism Therapeutics Market Size by Application (2023-2028)
7.3.3 Europe Venous Thromboembolism Therapeutics Market Share by Application (2017-2028)
7.4 Europe Venous Thromboembolism Therapeutics Market Size by Country
7.4.1 Europe Venous Thromboembolism Therapeutics Market Size by Country (2017-2022)
7.4.2 Europe Venous Thromboembolism Therapeutics Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Venous Thromboembolism Therapeutics Market Size (2017-2028)
8.2 Asia-Pacific Venous Thromboembolism Therapeutics Market Size by Type
8.2.1 Asia-Pacific Venous Thromboembolism Therapeutics Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Venous Thromboembolism Therapeutics Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Venous Thromboembolism Therapeutics Market Share by Type (2017-2028)
8.3 Asia-Pacific Venous Thromboembolism Therapeutics Market Size by Application
8.3.1 Asia-Pacific Venous Thromboembolism Therapeutics Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Venous Thromboembolism Therapeutics Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Venous Thromboembolism Therapeutics Market Share by Application (2017-2028)
8.4 Asia-Pacific Venous Thromboembolism Therapeutics Market Size by Region
8.4.1 Asia-Pacific Venous Thromboembolism Therapeutics Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Venous Thromboembolism Therapeutics Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Venous Thromboembolism Therapeutics Market Size (2017-2028)
9.2 Latin America Venous Thromboembolism Therapeutics Market Size by Type
9.2.1 Latin America Venous Thromboembolism Therapeutics Market Size by Type (2017-2022)
9.2.2 Latin America Venous Thromboembolism Therapeutics Market Size by Type (2023-2028)
9.2.3 Latin America Venous Thromboembolism Therapeutics Market Share by Type (2017-2028)
9.3 Latin America Venous Thromboembolism Therapeutics Market Size by Application
9.3.1 Latin America Venous Thromboembolism Therapeutics Market Size by Application (2017-2022)
9.3.2 Latin America Venous Thromboembolism Therapeutics Market Size by Application (2023-2028)
9.3.3 Latin America Venous Thromboembolism Therapeutics Market Share by Application (2017-2028)
9.4 Latin America Venous Thromboembolism Therapeutics Market Size by Country
9.4.1 Latin America Venous Thromboembolism Therapeutics Market Size by Country (2017-2022)
9.4.2 Latin America Venous Thromboembolism Therapeutics Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Venous Thromboembolism Therapeutics Market Size (2017-2028)
10.2 Middle East & Africa Venous Thromboembolism Therapeutics Market Size by Type
10.2.1 Middle East & Africa Venous Thromboembolism Therapeutics Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Venous Thromboembolism Therapeutics Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Venous Thromboembolism Therapeutics Market Share by Type (2017-2028)
10.3 Middle East & Africa Venous Thromboembolism Therapeutics Market Size by Application
10.3.1 Middle East & Africa Venous Thromboembolism Therapeutics Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Venous Thromboembolism Therapeutics Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Venous Thromboembolism Therapeutics Market Share by Application (2017-2028)
10.4 Middle East & Africa Venous Thromboembolism Therapeutics Market Size by Country
10.4.1 Middle East & Africa Venous Thromboembolism Therapeutics Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Venous Thromboembolism Therapeutics Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Details
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Venous Thromboembolism Therapeutics Introduction
11.1.4 Johnson & Johnson Revenue in Venous Thromboembolism Therapeutics Business (2017-2022)
11.1.5 Johnson & Johnson Recent Developments
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Venous Thromboembolism Therapeutics Introduction
11.2.4 Sanofi Revenue in Venous Thromboembolism Therapeutics Business (2017-2022)
11.2.5 Sanofi Recent Developments
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Details
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim Venous Thromboembolism Therapeutics Introduction
11.3.4 Boehringer Ingelheim Revenue in Venous Thromboembolism Therapeutics Business (2017-2022)
11.3.5 Boehringer Ingelheim Recent Developments
11.4 Daiichi Sankyo
11.4.1 Daiichi Sankyo Company Details
11.4.2 Daiichi Sankyo Business Overview
11.4.3 Daiichi Sankyo Venous Thromboembolism Therapeutics Introduction
11.4.4 Daiichi Sankyo Revenue in Venous Thromboembolism Therapeutics Business (2017-2022)
11.4.5 Daiichi Sankyo Recent Developments
11.5 Bristol-Myers Squibb (BMS)
11.5.1 Bristol-Myers Squibb (BMS) Company Details
11.5.2 Bristol-Myers Squibb (BMS) Business Overview
11.5.3 Bristol-Myers Squibb (BMS) Venous Thromboembolism Therapeutics Introduction
11.5.4 Bristol-Myers Squibb (BMS) Revenue in Venous Thromboembolism Therapeutics Business (2017-2022)
11.5.5 Bristol-Myers Squibb (BMS) Recent Developments
11.6 Bayer HealthCare
11.6.1 Bayer HealthCare Company Details
11.6.2 Bayer HealthCare Business Overview
11.6.3 Bayer HealthCare Venous Thromboembolism Therapeutics Introduction
11.6.4 Bayer HealthCare Revenue in Venous Thromboembolism Therapeutics Business (2017-2022)
11.6.5 Bayer HealthCare Recent Developments
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Venous Thromboembolism Therapeutics Introduction
11.7.4 Pfizer Revenue in Venous Thromboembolism Therapeutics Business (2017-2022)
11.7.5 Pfizer Recent Developments
11.8 Leo Pharma
11.8.1 Leo Pharma Company Details
11.8.2 Leo Pharma Business Overview
11.8.3 Leo Pharma Venous Thromboembolism Therapeutics Introduction
11.8.4 Leo Pharma Revenue in Venous Thromboembolism Therapeutics Business (2017-2022)
11.8.5 Leo Pharma Recent Developments
11.9 Portola Pharmaceuticals
11.9.1 Portola Pharmaceuticals Company Details
11.9.2 Portola Pharmaceuticals Business Overview
11.9.3 Portola Pharmaceuticals Venous Thromboembolism Therapeutics Introduction
11.9.4 Portola Pharmaceuticals Revenue in Venous Thromboembolism Therapeutics Business (2017-2022)
11.9.5 Portola Pharmaceuticals Recent Developments
11.10 ThromboGenics
11.10.1 ThromboGenics Company Details
11.10.2 ThromboGenics Business Overview
11.10.3 ThromboGenics Venous Thromboembolism Therapeutics Introduction
11.10.4 ThromboGenics Revenue in Venous Thromboembolism Therapeutics Business (2017-2022)
11.10.5 ThromboGenics Recent Developments
11.11 Ionis Pharmaceuticals
11.11.1 Ionis Pharmaceuticals Company Details
11.11.2 Ionis Pharmaceuticals Business Overview
11.11.3 Ionis Pharmaceuticals Venous Thromboembolism Therapeutics Introduction
11.11.4 Ionis Pharmaceuticals Revenue in Venous Thromboembolism Therapeutics Business (2017-2022)
11.11.5 Ionis Pharmaceuticals Recent Developments
11.12 GlycoMimetics
11.12.1 GlycoMimetics Company Details
11.12.2 GlycoMimetics Business Overview
11.12.3 GlycoMimetics Venous Thromboembolism Therapeutics Introduction
11.12.4 GlycoMimetics Revenue in Venous Thromboembolism Therapeutics Business (2017-2022)
11.12.5 GlycoMimetics Recent Developments
11.13 BioInvent International
11.13.1 BioInvent International Company Details
11.13.2 BioInvent International Business Overview
11.13.3 BioInvent International Venous Thromboembolism Therapeutics Introduction
11.13.4 BioInvent International Revenue in Venous Thromboembolism Therapeutics Business (2017-2022)
11.13.5 BioInvent International Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Venous Thromboembolism Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Factor Xa Inhibitors
Table 3. Key Players of Direct Thrombin Inhibitors
Table 4. Key Players of Heparin
Table 5. Key Players of Vitamin K Antagonists
Table 6. Key Players of Other
Table 7. Global Venous Thromboembolism Therapeutics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 8. Global Venous Thromboembolism Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Venous Thromboembolism Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Venous Thromboembolism Therapeutics Market Share by Region (2017-2022)
Table 11. Global Venous Thromboembolism Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Venous Thromboembolism Therapeutics Market Share by Region (2023-2028)
Table 13. Venous Thromboembolism Therapeutics Market Trends
Table 14. Venous Thromboembolism Therapeutics Market Drivers
Table 15. Venous Thromboembolism Therapeutics Market Challenges
Table 16. Venous Thromboembolism Therapeutics Market Restraints
Table 17. Global Venous Thromboembolism Therapeutics Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Venous Thromboembolism Therapeutics Revenue Share by Players (2017-2022)
Table 19. Global Top Venous Thromboembolism Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Venous Thromboembolism Therapeutics as of 2021)
Table 20. Ranking of Global Top Venous Thromboembolism Therapeutics Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Venous Thromboembolism Therapeutics Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Venous Thromboembolism Therapeutics Product Solution and Service
Table 24. Date of Enter into Venous Thromboembolism Therapeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Venous Thromboembolism Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Venous Thromboembolism Therapeutics Revenue Market Share by Type (2017-2022)
Table 28. Global Venous Thromboembolism Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Venous Thromboembolism Therapeutics Revenue Market Share by Type (2023-2028)
Table 30. Global Venous Thromboembolism Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Venous Thromboembolism Therapeutics Revenue Share by Application (2017-2022)
Table 32. Global Venous Thromboembolism Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Venous Thromboembolism Therapeutics Revenue Share by Application (2023-2028)
Table 34. North America Venous Thromboembolism Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 35. North America Venous Thromboembolism Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 36. North America Venous Thromboembolism Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 37. North America Venous Thromboembolism Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 38. North America Venous Thromboembolism Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 39. North America Venous Thromboembolism Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 40. Europe Venous Thromboembolism Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 41. Europe Venous Thromboembolism Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 42. Europe Venous Thromboembolism Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 43. Europe Venous Thromboembolism Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 44. Europe Venous Thromboembolism Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 45. Europe Venous Thromboembolism Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 46. Asia Pacific Venous Thromboembolism Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 47. Asia Pacific Venous Thromboembolism Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 48. Asia Pacific Venous Thromboembolism Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 49. Asia Pacific Venous Thromboembolism Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 50. Asia Pacific Venous Thromboembolism Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 51. Asia Pacific Venous Thromboembolism Therapeutics Market Size by Region (2023-2028) & (US$ Million)
Table 52. Latin America Venous Thromboembolism Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 53. Latin America Venous Thromboembolism Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 54. Latin America Venous Thromboembolism Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 55. Latin America Venous Thromboembolism Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 56. Latin America Venous Thromboembolism Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 57. Latin America Venous Thromboembolism Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Venous Thromboembolism Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Venous Thromboembolism Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Venous Thromboembolism Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Venous Thromboembolism Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 62. Middle East and Africa Venous Thromboembolism Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 63. Middle East and Africa Venous Thromboembolism Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 64. Johnson & Johnson Company Details
Table 65. Johnson & Johnson Business Overview
Table 66. Johnson & Johnson Venous Thromboembolism Therapeutics Product
Table 67. Johnson & Johnson Revenue in Venous Thromboembolism Therapeutics Business (2017-2022) & (US$ Million)
Table 68. Johnson & Johnson Recent Developments
Table 69. Sanofi Company Details
Table 70. Sanofi Business Overview
Table 71. Sanofi Venous Thromboembolism Therapeutics Product
Table 72. Sanofi Revenue in Venous Thromboembolism Therapeutics Business (2017-2022) & (US$ Million)
Table 73. Sanofi Recent Developments
Table 74. Boehringer Ingelheim Company Details
Table 75. Boehringer Ingelheim Business Overview
Table 76. Boehringer Ingelheim Venous Thromboembolism Therapeutics Product
Table 77. Boehringer Ingelheim Revenue in Venous Thromboembolism Therapeutics Business (2017-2022) & (US$ Million)
Table 78. Boehringer Ingelheim Recent Developments
Table 79. Daiichi Sankyo Company Details
Table 80. Daiichi Sankyo Business Overview
Table 81. Daiichi Sankyo Venous Thromboembolism Therapeutics Product
Table 82. Daiichi Sankyo Revenue in Venous Thromboembolism Therapeutics Business (2017-2022) & (US$ Million)
Table 83. Daiichi Sankyo Recent Developments
Table 84. Bristol-Myers Squibb (BMS) Company Details
Table 85. Bristol-Myers Squibb (BMS) Business Overview
Table 86. Bristol-Myers Squibb (BMS) Venous Thromboembolism Therapeutics Product
Table 87. Bristol-Myers Squibb (BMS) Revenue in Venous Thromboembolism Therapeutics Business (2017-2022) & (US$ Million)
Table 88. Bristol-Myers Squibb (BMS) Recent Developments
Table 89. Bayer HealthCare Company Details
Table 90. Bayer HealthCare Business Overview
Table 91. Bayer HealthCare Venous Thromboembolism Therapeutics Product
Table 92. Bayer HealthCare Revenue in Venous Thromboembolism Therapeutics Business (2017-2022) & (US$ Million)
Table 93. Bayer HealthCare Recent Developments
Table 94. Pfizer Company Details
Table 95. Pfizer Business Overview
Table 96. Pfizer Venous Thromboembolism Therapeutics Product
Table 97. Pfizer Revenue in Venous Thromboembolism Therapeutics Business (2017-2022) & (US$ Million)
Table 98. Pfizer Recent Developments
Table 99. Leo Pharma Company Details
Table 100. Leo Pharma Business Overview
Table 101. Leo Pharma Venous Thromboembolism Therapeutics Product
Table 102. Leo Pharma Revenue in Venous Thromboembolism Therapeutics Business (2017-2022) & (US$ Million)
Table 103. Leo Pharma Recent Developments
Table 104. Portola Pharmaceuticals Company Details
Table 105. Portola Pharmaceuticals Business Overview
Table 106. Portola Pharmaceuticals Venous Thromboembolism Therapeutics Product
Table 107. Portola Pharmaceuticals Revenue in Venous Thromboembolism Therapeutics Business (2017-2022) & (US$ Million)
Table 108. Portola Pharmaceuticals Recent Developments
Table 109. ThromboGenics Company Details
Table 110. ThromboGenics Business Overview
Table 111. ThromboGenics Venous Thromboembolism Therapeutics Product
Table 112. ThromboGenics Revenue in Venous Thromboembolism Therapeutics Business (2017-2022) & (US$ Million)
Table 113. ThromboGenics Recent Developments
Table 114. Ionis Pharmaceuticals Company Details
Table 115. Ionis Pharmaceuticals Business Overview
Table 116. Ionis Pharmaceuticals Venous Thromboembolism Therapeutics Product
Table 117. Ionis Pharmaceuticals Revenue in Venous Thromboembolism Therapeutics Business (2017-2022) & (US$ Million)
Table 118. Ionis Pharmaceuticals Recent Developments
Table 119. GlycoMimetics Company Details
Table 120. GlycoMimetics Business Overview
Table 121. GlycoMimetics Venous Thromboembolism Therapeutics Product
Table 122. GlycoMimetics Revenue in Venous Thromboembolism Therapeutics Business (2017-2022) & (US$ Million)
Table 123. GlycoMimetics Recent Developments
Table 124. BioInvent International Company Details
Table 125. BioInvent International Business Overview
Table 126. BioInvent International Venous Thromboembolism Therapeutics Product
Table 127. BioInvent International Revenue in Venous Thromboembolism Therapeutics Business (2017-2022) & (US$ Million)
Table 128. BioInvent International Recent Developments
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Venous Thromboembolism Therapeutics Market Share by Type: 2021 VS 2028
Figure 2. Factor Xa Inhibitors Features
Figure 3. Direct Thrombin Inhibitors Features
Figure 4. Heparin Features
Figure 5. Vitamin K Antagonists Features
Figure 6. Other Features
Figure 7. Global Venous Thromboembolism Therapeutics Market Share by Application: 2021 VS 2028
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Other Case Studies
Figure 11. Venous Thromboembolism Therapeutics Report Years Considered
Figure 12. Global Venous Thromboembolism Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Venous Thromboembolism Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Venous Thromboembolism Therapeutics Market Share by Region: 2021 VS 2028
Figure 15. Global Venous Thromboembolism Therapeutics Market Share by Players in 2021
Figure 16. Global Top Venous Thromboembolism Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Venous Thromboembolism Therapeutics as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Venous Thromboembolism Therapeutics Revenue in 2021
Figure 18. North America Venous Thromboembolism Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 19. North America Venous Thromboembolism Therapeutics Market Size Market Share by Type (2017-2028)
Figure 20. North America Venous Thromboembolism Therapeutics Market Size Market Share by Application (2017-2028)
Figure 21. North America Venous Thromboembolism Therapeutics Market Size Share by Country (2017-2028)
Figure 22. United States Venous Thromboembolism Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Canada Venous Thromboembolism Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Venous Thromboembolism Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 25. Europe Venous Thromboembolism Therapeutics Market Size Market Share by Type (2017-2028)
Figure 26. Europe Venous Thromboembolism Therapeutics Market Size Market Share by Application (2017-2028)
Figure 27. Europe Venous Thromboembolism Therapeutics Market Size Share by Country (2017-2028)
Figure 28. Germany Venous Thromboembolism Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. France Venous Thromboembolism Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. U.K. Venous Thromboembolism Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Italy Venous Thromboembolism Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Russia Venous Thromboembolism Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Nordic Countries Venous Thromboembolism Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Venous Thromboembolism Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 35. Asia Pacific Venous Thromboembolism Therapeutics Market Size Market Share by Type (2017-2028)
Figure 36. Asia Pacific Venous Thromboembolism Therapeutics Market Size Market Share by Application (2017-2028)
Figure 37. Asia Pacific Venous Thromboembolism Therapeutics Market Size Share by Region (2017-2028)
Figure 38. China Venous Thromboembolism Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Japan Venous Thromboembolism Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. South Korea Venous Thromboembolism Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Southeast Asia Venous Thromboembolism Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. India Venous Thromboembolism Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Australia Venous Thromboembolism Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 44. Latin America Venous Thromboembolism Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 45. Latin America Venous Thromboembolism Therapeutics Market Size Market Share by Type (2017-2028)
Figure 46. Latin America Venous Thromboembolism Therapeutics Market Size Market Share by Application (2017-2028)
Figure 47. Latin America Venous Thromboembolism Therapeutics Market Size Share by Country (2017-2028)
Figure 48. Mexico Venous Thromboembolism Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Brazil Venous Thromboembolism Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Middle East & Africa Venous Thromboembolism Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 51. Middle East and Africa Venous Thromboembolism Therapeutics Market Size Market Share by Type (2017-2028)
Figure 52. Middle East and Africa Venous Thromboembolism Therapeutics Market Size Market Share by Application (2017-2028)
Figure 53. Middle East and Africa Venous Thromboembolism Therapeutics Market Size Share by Country (2017-2028)
Figure 54. Turkey Venous Thromboembolism Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Saudi Arabia Venous Thromboembolism Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. UAE Venous Thromboembolism Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. Johnson & Johnson Revenue Growth Rate in Venous Thromboembolism Therapeutics Business (2017-2022)
Figure 58. Sanofi Revenue Growth Rate in Venous Thromboembolism Therapeutics Business (2017-2022)
Figure 59. Boehringer Ingelheim Revenue Growth Rate in Venous Thromboembolism Therapeutics Business (2017-2022)
Figure 60. Daiichi Sankyo Revenue Growth Rate in Venous Thromboembolism Therapeutics Business (2017-2022)
Figure 61. Bristol-Myers Squibb (BMS) Revenue Growth Rate in Venous Thromboembolism Therapeutics Business (2017-2022)
Figure 62. Bayer HealthCare Revenue Growth Rate in Venous Thromboembolism Therapeutics Business (2017-2022)
Figure 63. Pfizer Revenue Growth Rate in Venous Thromboembolism Therapeutics Business (2017-2022)
Figure 64. Leo Pharma Revenue Growth Rate in Venous Thromboembolism Therapeutics Business (2017-2022)
Figure 65. Portola Pharmaceuticals Revenue Growth Rate in Venous Thromboembolism Therapeutics Business (2017-2022)
Figure 66. ThromboGenics Revenue Growth Rate in Venous Thromboembolism Therapeutics Business (2017-2022)
Figure 67. Ionis Pharmaceuticals Revenue Growth Rate in Venous Thromboembolism Therapeutics Business (2017-2022)
Figure 68. GlycoMimetics Revenue Growth Rate in Venous Thromboembolism Therapeutics Business (2017-2022)
Figure 69. BioInvent International Revenue Growth Rate in Venous Thromboembolism Therapeutics Business (2017-2022)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Thyroid Gland Disorders Treatment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 80

Thyroid Gland Disorder Treatment is a kind of treatment method, which aims to The thyroid disorder patients, such as hypothyroidism patients and hyperthyroidism patients. When The thyroid gland does not produce sufficient hypothyroidism or too much hyperthyroidism, The body metabolism and functioning will be disrupted. The global Thyroid Gland Disorders Treatment market was valued at US$ 2950 million in 2023 and is anticipated to reach US$ 3871.9 million by 2030, witnessing a CAGR o......

Global Brachytherapy Afterloaders, Brachytherapy Seeds Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 98

According to our LPI (LP Information) latest study, the global Brachytherapy Afterloaders, Brachytherapy Seeds market size was valued at US$ 150.8 million in 2023. With growing demand in downstream market, the Brachytherapy Afterloaders, Brachytherapy Seeds is forecast to a readjusted size of US$ 168.1 million by 2030 with a CAGR of 1.6% during review period. The research report highlights the growth potential of the global Brachytherapy Afterloaders, Brachytherapy Seeds market. Brachyth......

Global Peptide Therapeutics Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109

According to our LPI (LP Information) latest study, the global Peptide Therapeutics market size was valued at US$ 33800 million in 2023. With growing demand in downstream market, the Peptide Therapeutics is forecast to a readjusted size of US$ 63130 million by 2030 with a CAGR of 9.3% during review period. The research report highlights the growth potential of the global Peptide Therapeutics market. Peptide Therapeutics are expected to show stable growth in the future market. However, pr......

Global Microbiome Therapeutics Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 155

According to our LPI (LP Information) latest study, the global Microbiome Therapeutics market size was valued at US$ 89 million in 2023. With growing demand in downstream market, the Microbiome Therapeutics is forecast to a readjusted size of US$ 916.3 million by 2030 with a CAGR of 39.5% during review period. The research report highlights the growth potential of the global Microbiome Therapeutics market. Microbiome Therapeutics are expected to show stable growth in the future market. H......

Global Anti-inflammatory Therapeutics Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109

According to our LPI (LP Information) latest study, the global Anti-inflammatory Therapeutics market size was valued at US$ 108140 million in 2023. With growing demand in downstream market, the Anti-inflammatory Therapeutics is forecast to a readjusted size of US$ 166150 million by 2030 with a CAGR of 6.3% during review period. The research report highlights the growth potential of the global Anti-inflammatory Therapeutics market. Anti-inflammatory Therapeutics are expected to show stabl......

Global Enzyme Replacement Therapy Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 113

According to our LPI (LP Information) latest study, the global Enzyme Replacement Therapy market size was valued at US$ 11570 million in 2023. With growing demand in downstream market, the Enzyme Replacement Therapy is forecast to a readjusted size of US$ 29900 million by 2030 with a CAGR of 14.5% during review period. The research report highlights the growth potential of the global Enzyme Replacement Therapy market. Enzyme Replacement Therapy are expected to show stable growth in the f......

Global Infantile Spasms Therapeutics Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 84

According to our LPI (LP Information) latest study, the global Infantile Spasms Therapeutics market size was valued at US$ 138.9 million in 2023. With growing demand in downstream market, the Infantile Spasms Therapeutics is forecast to a readjusted size of US$ 179.6 million by 2030 with a CAGR of 3.7% during review period. The research report highlights the growth potential of the global Infantile Spasms Therapeutics market. Infantile Spasms Therapeutics are expected to show stable grow......

Global Hormone Replacement Therapy Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 128

According to our LPI (LP Information) latest study, the global Hormone Replacement Therapy market size was valued at US$ 16090 million in 2023. With growing demand in downstream market, the Hormone Replacement Therapy is forecast to a readjusted size of US$ 17930 million by 2030 with a CAGR of 1.6% during review period. The research report highlights the growth potential of the global Hormone Replacement Therapy market. Hormone Replacement Therapy are expected to show stable growth in th......

Global Plasma Therapy Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 107

According to our LPI (LP Information) latest study, the global Plasma Therapy market size was valued at US$ 265.3 million in 2023. With growing demand in downstream market, the Plasma Therapy is forecast to a readjusted size of US$ 529.4 million by 2030 with a CAGR of 10.4% during review period. The research report highlights the growth potential of the global Plasma Therapy market. Plasma Therapy are expected to show stable growth in the future market. However, product differentiation, ......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs